Home > Boards > US Listed > Biotechs > Can-Fite BioPharma (CANF)

I have invited the SEC to look at

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
keekee Member Profile
 
Followed By 108
Posts 4,097
Boards Moderated 0
Alias Born 09/29/11
160x600 placeholder
Can-Fite to Participate in Three Upcoming Pharma Partnering Conferences Business Wire - 9/17/2021 7:00:00 AM
Can-Fite to Present at the H.C. Wainwright 23rd Annual Global Investment Conference Business Wire - 9/9/2021 7:00:00 AM
Can-Fite Completes Patient Enrollment in Phase III Psoriasis Study Business Wire - 9/2/2021 7:00:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/2/2021 6:05:15 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 9/1/2021 4:31:26 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/1/2021 6:10:34 AM
Securities Registration (foreign Private Issuer) (f-1) Edgar (US Regulatory) - 8/26/2021 4:32:22 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 8/26/2021 4:31:32 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 8/26/2021 4:31:26 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/26/2021 7:29:41 AM
Can-Fite Reports Second Quarter 2021 Financial Results & Provides Clinical Update Business Wire - 8/26/2021 7:00:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/16/2021 10:22:37 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/13/2021 4:47:05 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/12/2021 8:13:43 AM
Can-Fite Announces $10.0 Million Registered Direct Offering Business Wire - 8/12/2021 8:00:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/5/2021 9:22:45 AM
Yossi Borenstein, CEO and Founder of Shizim Group, has been Elected to the Can-Fite Board Business Wire - 8/5/2021 9:18:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 7/29/2021 4:32:28 PM
Can-Fite set to begin enrollment in phase 3 liver cancer candidate study Seeking Alpha - 7/8/2021 8:11:03 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 7/8/2021 7:06:45 AM
Can-Fite Gears Up to Initiate Pivotal Phase III Liver Cancer Study Business Wire - 7/8/2021 7:00:00 AM
Can-Fite shares rise 8% on piclidenoson development deal for pets Seeking Alpha - 6/28/2021 7:35:35 AM
Can-Fite Enters Projected $3 Billion Veterinary Osteoarthritis Market: Signs Agreement with Vetbiolix for Development of Picl... Business Wire - 6/28/2021 7:00:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 6/23/2021 4:31:15 PM
Can-Fite gets notice of patent allowance in china for NASH treatment Seeking Alpha - 6/16/2021 7:57:55 AM
keekee   Wednesday, 10/21/20 09:58:04 AM
Re: keekee post# 1591
Post # of 1706 
I have invited the SEC to look at the tapes of these stocks. I supplied ten stocks and I do hope that the SEC acts to protect this primary mission.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences